Atypical Hemolytic Uremic Syndrome Triggered by COVID ‐19 Infection in a Pediatric Patient With CD46 Mutation
Clinical Case Reports · 2025-03 · 13 (3)
DOI: 10.1002/ccr3.70308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 14.03.2025. Verfasst von Parsa Lorestani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Students Research Committee Kermanshah University of Medical Sciences Kermanshah Iran. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) that is considered life‐threatening and caused by dysregulation of the complement system. Here, we report a previously healthy 8‐year‐old boy who presented with features of aHUS 1 week after viral symptoms during the COVID‐19 pandemic. The patient was initially admitted for viral symptoms, pallor, edema, and urine color changes. Laboratory tests revealed anemia, thrombocytopenia, and elevated levels of creatinine and blood urea nitrogen (BUN). Despite fluid and electrolyte management, he developed pulmonary edema, necessitating hemodialysis and plasmapheresis. Genetic testing identified a homozygous pathogenic mutation in the CD46 gene, which encodes membrane cofactor protein (MCP). While initially responding to treatment, the patient experienced a relapse, requiring further interventions including eculizumab therapy. This case highlights the potential of COVID‐19 to trigger complement‐mediated TMA and emphasizes the importance of prompt diagnosis, genetic assessment, and targeted complement inhibition in managing aHUS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Students Research Committee Kermanshah University of Medical Sciences Kermanshah Iran.
- Research Center for Biochemistry and Nutrition in Metabolic Diseases Kashan University of Medical Sciences Kashan Iran.
- Department of Pediatric Nephrology, Urology and Nephrology Research Center Kermanshah University of Medical Sciences Kermanshah Iran.
ORCID-Profile: Parsa Lorestani, Parisa Maleki Dana, Mohamad Reza Tohidi
Zitieren
APA
Lorestani, P., Maleki Dana, P., & Tohidi, M. R. (2025). Atypical Hemolytic Uremic Syndrome Triggered by COVID ‐19 Infection in a Pediatric Patient With CD46 Mutation. Clinical Case Reports, 13(3). https://doi.org/10.1002/ccr3.70308
Vancouver
Lorestani P, Maleki Dana P, Tohidi MR. Atypical Hemolytic Uremic Syndrome Triggered by COVID ‐19 Infection in a Pediatric Patient With CD46 Mutation. Clinical Case Reports. 2025;13(3). doi:10.1002/ccr3.70308
BibTeX
@article{Lorestani2025,
author = {Lorestani, Parsa and Maleki Dana, Parisa and Tohidi, Mohamad Reza},
title = {Atypical Hemolytic Uremic Syndrome Triggered by COVID ‐19 Infection in a Pediatric Patient With CD46 Mutation},
journal = {Clinical Case Reports},
year = {2025},
volume = {13},
number = {3},
doi = {10.1002/ccr3.70308}
}
EUVIMED